Ma et al. [32] reported that 2-methoxyestradiol repressed nuclear translocation and expression of HIF-1α and HIF-2α, synergizing with sorafenib to stop tumoral proliferation and induce apoptosis of HCC cells. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.